Ratings by Rothschild Redburn
| Date | Analyst | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|---|
| 9/3/2026 | Simon Baker | Moderna | MRNA | Downgrade | Sell (Neutral) |
81.00 (40.00) |
154.27 (145.55) |
-5.65% | Details |
| 9/2/2026 | Natalya Davies | Mettler-Toledo | MTD | New Coverage | Sell (N/A) |
1,200.00 (N/A) |
1405.14 (1345.26) |
-4.26% | Details |
 |
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
| 363 more... | |||||||||
